Yevgen Chornenkyy

Dr. Yevgen Chornenkyy

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in Antioxidants
Verified
Journal Article
Open access
PDF file
ZZZhengqiu Zhou
Zhengqiu Zhou
EIElochukwu Ibekwe
Elochukwu Ibekwe
YCYevgen Chornenkyy
Yevgen Chornenkyy
The mitochondrion is an important organelle and provides energy for a plethora of intracellular reactions. Metabolic dysregulation has dire consequences for the cell, and alteration in metabolism has been identified in multiple disease states—cancer being one. Otto Warburg demonstrated that cancer cells, in the presence of oxygen, undergo glycolysis by reprogramming their metabolism—termed “aerobic glycolysis”. Alterations in metabolism enable cancer cells to gain a growth advantage by obtaining precursors for macromolecule biosynthesis, such as nucleic acids and lipids. To date, several molecules, termed “oncometabolites”, have been identified to be elevated in cancer cells and arise from mutations in nuclear encoded mitochondrial enzymes. Furthermore, there is evidence that oncometabolites can affect mitochondrial dynamics. It is believed that oncometabolites can assist in reprogramming enzymatic pathways and providing cancer cells with selective advantages. In this review, we will touch upon the effects of normal and aberrant mitochondrial metabolism in normal and cancer cells, the advantages of metabolic reprogramming, effects of oncometabolites on metabolism and mitochondrial dynamics and therapies aimed at targeting oncometabolites and metabolic aberrations.

20 November 2023 in Academic Pathology
Verified
Journal Article
Open access
CFChristopher Felicelli
Christopher Felicelli
AGAlcino Gama
Alcino Gama
YCYevgen Chornenkyy
Yevgen Chornenkyy
BCBonnie Choy
Bonnie Choy
LBLuis Z. Blanco
Luis Z. Blanco
JNJorge E. Novo
Jorge E. Novo
Over the past decade, competency-based medical education (CBME) has gained momentum in the United States to develop trainees into independent and confident physicians by the end of their training. Entrustable professional activities (EPAs) are an established methodology for assessing trainee development through an outcomes-driven rather than a time-based model. While EPAs have been utilized as an assessment tool for CBME in Europe and Canada, their validation and implementation in some medical specialties has occurred more recently in the United States. Pediatrics was the first specialty in the US to conduct a large-scale UME-GME pilot. Pathology Residency EPAs were published in 2018; however, implementation in training programs has been slow. We have piloted EPAs in our residency program's surgical pathology rotation and propose a unique set of 4 surgical pathology EPAs to track trainee preparedness for independent practice.

3 September 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EIElochukwu Ibekwe
Elochukwu Ibekwe
NHNeil B. Horsley
Neil B. Horsley
LJLan Jiang
Lan Jiang
NANadine-Stella Achenjang
Nadine-Stella Achenjang
AAAzubuogu Anudu
Azubuogu Anudu
YCYevgen Chornenkyy
Yevgen Chornenkyy
Central Nervous System (CNS) involvement in multiple myeloma and/or multifocal solitary plasmacytoma is rare. Although they are unique entities, multiple myeloma (MM) and plasmacytoma represent a spectrum of plasma cell neoplastic diseases that can sometimes occur concurrently. Plasmacytomas very often present as late-stage sequelae of MM. In this case report, we report a 53-year-old female presenting with right abducens cranial nerve (CN) VI palsy as an initial presentation secondary to lesion of the right clivus.


16 September 2024 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
YCYevgen Chornenkyy
Yevgen Chornenkyy
CLCarissa LaBoy
Carissa LaBoy
SHSergei Xavier De Hoyos
Sergei Xavier De Hoyos
JHJingjing Hu
Jingjing Hu
MPMaryam Pezhouh
Maryam Pezhouh
Aims: Widespread use of immune checkpoint inhibitors (ICIs) for treatment of advanced malignancies led to an increase in number of immune-related adverse events such as ICI gastrointestinal (GI) injury (ICIGI). The resulting immune dysregulation of the GI mucosa is believed to predispose patients to viral infections. We characterised the histopathological features of ICIGI and the frequency of viral infections such as cytomegalovirus (CMV), adenovirus, and Epstein-Barr virus (EBV). Methods: Single-centre retrospective study (2011–2020). Results: 81 GI biopsies from 31 patients with ICIGI (65% male (20/31), 35% female (11/31)) with advanced malignancies were reviewed. Most patients received ipilimumab and nivolumab (14/31, 45%), followed by pembrolizumab (9/31, 29%), ipilimumab (4/31, 13%), nivolumab (2/31, 6%) and combination of all three medications (2/31, 6%). Average regimen prior to incidence of diarrhea was three cycles. Evidence of colitis or erythema by endoscopy was present in 77% of cases, while 23% showed normal endoscopy. Histologically, the predominant ICIGI findings were active inflammation (84%), including cryptitis (77%), crypt abscesses (65%), lymphocytic colitis-like (LCL) pattern (61%), increase in epithelial apoptosis (74%) and/or surface injury (81%). Only one case showed diffuse CMV positivity (3%) with characteristic CMV viral cytopathic effects present on H&E stain and four cases were positive for rare EBV (13%). Adenovirus infection was not identified. Conclusion: While our cohort is small, ICIGI generally demonstrates active inflammation including cryptitis and crypt abscesses in the colon, LCL pattern, and an increase in epithelial apoptosis. Upfront immunohistochemistry for viral infection without high-degree of clinical and histologic suspicion is not recommended.

11 May 2022 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
CFChristopher Felicelli
Christopher Felicelli
JRJoseph Reznicek
Joseph Reznicek
YCYevgen Chornenkyy
Yevgen Chornenkyy
LJLucy Jager
Lucy Jager
DJDaniel Johnson
Daniel Johnson